IndraLab

Statements

Abacavir inhibits IFNB1. 1 / 1

| 1

reach

"Lenalidomide, a drug showing clinical activity against DLBCL, antagonizes a central regulatory hub in ABC DLBCL governed by IRF4 and SPIB, which together suppress IFNbeta while augmenting NFkappaB activity."

23243601

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Abacavir inhibits IFNB1. 1 / 1

INDRA sources:

Databases

Reading